A phase II study of radioimmunotherapy with intraventricular 131 I-3F8 for medulloblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A phase II study of radioimmunotherapy with intraventricular 131 I-3F8 for medulloblastoma

Published:2017-09-22 Issue:1 Volume:65 Page:e26754
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Kramer Kim¹,Pandit-Taskar Neeta²,Humm John L.²,Zanzonico Pat B.²,Haque Sofia²,Dunkel Ira J.¹,Wolden Suzanne L.³,Donzelli Maria¹,Goldman Debra A.⁴,Lewis Jason S.²,Lyashchenko Serge K.²,Khakoo Yasmin¹,Carrasquillo Jorge A.²,Souweidane Mark M.⁵,Greenfield Jeffrey P.⁵,Lyden David¹,De Braganca Kevin D.¹,Gilheeney Stephen W.¹,Larson Steven M.²,Cheung Nai-Kong V.¹

Affiliation:

1. Department of Pediatrics; Memorial Sloan Kettering Cancer Center; New York

2. Department of Radiology (Molecular Imaging and Therapy Service); Memorial Sloan Kettering Cancer Center; New York

3. Department of Radiation Oncology; Memorial Sloan Kettering Cancer Center; New York

4. Department of Epidemiology & Biostatistics; Weill Cornell Medical College; New York

5. Department of Neurosurgery; Weill Cornell Medical College; New York

Funder

Robert Steel Foundation

Catie Hoch Foundation

Katie's Find A Cure Fund

Pediatric Cancer Foundation

Leptomeningeal Research Fund

National Cancer Institute

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference31 articles.

1. Phase I study of temozolomide in combination with thiotepa and carboplatin with autologous hematopoietic cell rescue in patients with malignant brain tumors with minimal residual disease;Egan;Bone Marrow Transplant,2016

2. High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group;Dunkel;J Clin Oncol,1998

3. Efficacy of high-dose chemotherapy or standard salvage therapy in patients with recurrent medulloblastoma;Gururangan;Neuro-Oncology,2008

4. Phase I study of targeted radioimmunotherapy for leptomeningeal cancers using intra-Ommaya 131-I-3F8;Kramer;J Clin Oncol,2007

5. Immunoreactivity, pharmacokinetics and bone marrow dosimetry of intrathecal radioimmunoconjugates;Moseley;Int J Cancer,1992

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protocol for assessing GD2 on formalin-fixed paraffin-embedded tissue sections using immunofluorescence staining;STAR Protocols;2024-09

2. Craniospinal irradiation and/or intraventricular radioimmunotherapy after high‐dose chemotherapy and autologous stem cell rescue in patients with CNS retinoblastoma—Safety and outcomes;Pediatric Blood & Cancer;2024-08-31

3. Mechanistic insights into medulloblastoma relapse;Pharmacology & Therapeutics;2024-08

4. Personalized treatment options of refractory and relapsed medulloblastoma in children: literature review;Journal of Modern Oncology;2024-02-21

5. Effective re-induction regimen for children with recurrent medulloblastoma;Neuro-Oncology Advances;2024-01-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3